Recently, such IHC:MYC(+)/LMO2(−) staining was found to be significantly associated with MYCR in CD10(+)BCL, including BL [7, 38], and consistent with low levels of LMO2 expression in MYC-positive BL [39]. This evidence concerns the gene MYC and Burkitt lymphoma.